glp-1 lower cholesterol Most people see GLP-1s as “weight loss drugs.” What's actually happening is a shift in metabolic function. receptor agonists work on the brain–gut axis to regulate appetite, improve insulin signaling, and Can glucagon-like peptide-1 (GLP-1) receptor

Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant

Mild nausea and constipation are common but temporary during the first 12 weeks at each new dose level

This involves slowly reducing the dose over time to minimize withdrawal effects and weight regain

The development of GLP-1 medications like Ozempic/Wegovy (semaglutide) and GIP/GLP-1 agonists like Mounjaro/Zepbound (tirzepatide) have been game changers when it comes to treating type 2 diabetes and obesity

The main source in our diet is meat